000 | 01430 a2200373 4500 | ||
---|---|---|---|
005 | 20250515172202.0 | ||
264 | 0 | _c20100126 | |
008 | 201001s 0 0 eng d | ||
022 | _a1555-8576 | ||
024 | 7 |
_a10.4161/cbt.8.9.8403 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHertan, Lauren M | |
245 | 0 | 0 |
_aPiling up the JNK: drug synergy through ER stress. _h[electronic resource] |
260 |
_bCancer biology & therapy _cMay 2009 |
||
300 |
_a820-2 p. _bdigital |
||
500 | _aPublication Type: Comment; Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
650 | 0 | 4 |
_aBenzopyrans _xadministration & dosage |
650 | 0 | 4 |
_aBoronic Acids _xadministration & dosage |
650 | 0 | 4 | _aBortezomib |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEndoplasmic Reticulum _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xmetabolism |
650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
650 | 0 | 4 |
_aNitriles _xadministration & dosage |
650 | 0 | 4 |
_aProtease Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aPyrazines _xadministration & dosage |
650 | 0 | 4 | _aSignal Transduction |
700 | 1 | _aKoumenis, Constantinos | |
773 | 0 |
_tCancer biology & therapy _gvol. 8 _gno. 9 _gp. 820-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4161/cbt.8.9.8403 _zAvailable from publisher's website |
999 |
_c18884769 _d18884769 |